SCHEMBL18518471

SCHEMBL18518471

Cc1cc(-c2ccc(=O)n(C)c2)cc(C)c1N

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ BRD4 O60885 9/20 0.47
▸ TLR4 O00206 2/20 0.45
▸ TLR8 Q9NR97 2/20 0.45
▸ TLR9 Q9NR96 1/20 0.45
▸ TLR7 Q9NYK1 1/20 0.45
▸ BRD9 Q9H8M2 2/20 0.43
▸ CREBBP Q92793 4/20 0.39
▸ BMPR1B O00238 1/20 0.39
▸ BMPR1A P36894 1/20 0.39
▸ ACVRL1 P37023 1/20 0.39
▸ ACVR1 Q04771 1/20 0.39
▸ DYRK1A Q13627 1/20 0.39
▸ ADORA2A P29274 2/20 0.38
▸ ADORA1 P30542 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18471235 0.85 BRD4 (0.50) BRD4TLR4TLR8TLR9TLR7
SCHEMBL15262095 0.82 BRD4 (0.47) BRD4TLR4TLR8TLR9TLR7
SCHEMBL1571625 0.81 BRD4 (0.50) BRD4TLR4TLR8TLR9TLR7
SCHEMBL18483006 0.79 BRD4 (0.51) BRD4TLR4TLR8TLR9TLR7
SCHEMBL18647162 0.79 BRD4 (0.47) BRD4TLR4TLR8TLR9TLR7
SCHEMBL25258561 0.77 BRD4 (0.49) ALDH1A1TP53CYP3A4TDP1BRD4
SCHEMBL13680661 0.75 BRD4 (0.64) ALDH1A1BRD4CREBBPBMPR1BBMPR1A
SCHEMBL18518469 0.75 ALDH1A1 (0.50) ALDH1A1TP53CYP3A4TSHRTDP1
SCHEMBL16573986 0.75 BRD4 (0.50) BRD4CREBBPBMPR1BBMPR1AACVRL1
SCHEMBL15889927 0.74 BRD4 (0.50) TSHRBRD4TLR4TLR8TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3573959-B1 BENZYLAMINOPYRAZINYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INT (DE) 2021-07-28 — — EP disclosed
EP-3573952-B1 BENZYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICALCOMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INT (DE) 2021-07-14 — — EP disclosed
EP-3573965-B1 INDANYLAMINOPYRAZINYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INT (DE) 2021-06-23 — — EP disclosed
EP-3544958-B1 INDANYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INT (DE) 2021-03-24 — — EP disclosed
EP-3532458-B1 BENZYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INT (DE) 2021-01-20 — — EP disclosed
EP-3331860-B1 INDANYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INT (DE) 2019-07-17 — — EP disclosed
WO-2018138026-A1 INDANYLAMINOPYRAZINYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2018-08-02 — — WO disclosed
WO-2018138027-A1 BENZYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICALCOMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2018-08-02 — — WO disclosed
WO-2018077699-A1 BENZYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2018-05-03 — — WO disclosed
WO-2017025368-A1 INDANYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2017-02-16 — — WO disclosed
Send feedback